Worldwide, an estimated one in five pregnant women carries the group B Strep (GBS) bacteria which is a major, yet preventable, cause of maternal and infant ill health globally. These are the findings of a new research supplement published in the journal Clinical Infectious Diseases, and launched at the American Society of Tropical Medicine and Hygiene Annual Meeting in Baltimore. Led by the London School of Hygiene & Tropical Medicine and involving more than 100 researchers from around the world, the series of 11 research papers conservatively estimates that out of 410,000 GBS cases every year, there will be at least 147,000 stillbirths and infant deaths globally. This first comprehensive study of the burden of GBS, funded by a grant from [...]
About Oliver PlumbThis author has not yet filled in any details.
So far Oliver Plumb has created 137 blog entries.
As 'vaginal seeding' has been featured prominently in the news this week, often mentioning group B Strep, we thought it would be helpful to make our position on vaginal seeding clear. Our Medical Advisory Panel's view is this: "The practice of ‘vaginal seeding’ babies born by Caesarean (putting a gauze swab in the vagina for 24 hours beforehand and then wiping the baby’s mouth and skin with that gauze after birth) is increasingly attracting attention. The hope is that exposure to bacteria will boost the baby’s immune system, thereby preventing illness and disease in the future, such as asthma and allergies. Group B Strep Support does not recommend this practice because there is no properly conducted clinical trial that [...]
Group B Strep Support and Royal College team up to provide patient information leaflet on group B Strep
We are delighted to announce we're working with the Royal College of Obstetricians & Gynaecologists (RCOG) to produce a clear and concise patient information leaflet on group B Strep to be given to all pregnant women. The leaflet is based on the RCOG's Green-top Guideline on group B Strep (due to be published in September 2017). This is a huge step forward in the campaign to prevent GBS infection in new babies, as for the first time, all pregnant women will be given information about group B Strep as a routine part of antenatal care. A key part of the process of developing the information leaflet is the peer review process - comments are welcomed on the draft Group B Streptococcus [...]
We are delighted to announce there will be an International Symposium on 'Streptococcus agalactiae' Disease (ISSAD) in Cape Town, South Africa from 20-23 February 2018, held with the generous support of the Bill & Melinda Gates Foundation Our Chief Executive, Jane Plumb MBE, is a member of the International Scientific Committee, and has been asked to coordinate the session on advocacy for group B Strep prevention strategies, including group B Strep vaccines. This inaugural symposium will bring together experts and key stakeholders in various fields of GBS for enhanced collaboration, advance the thinking, and exchange ideas aimed at progressing towards a GBS-disease-free population. All researchers, clinicians, healthcare and public health practitioners are welcome to join in sharing ideas, [...]
Prior to the birth of my third baby I had never heard of Strep B. I like to read, listen to the radio, keep up with the news, am married to a doctor, was already a mother and friends with other parents. So, right there we have a clue to lack of public awareness. My son was born in 2004, so this may well have changed. I hope so. My first babies were twins. They were born at 33 weeks and spent time in “special care” before they were resilient enough to come home. Perhaps because a hospitalised experience was necessary with them I was keen to have a home birth next time around. Everything seemed to be [...]
Group B Strep Support is encouraged by the news that clinical trials of a group B Strep vaccine have begun. Pharmaceutical company Pfizer has started a Phase 1 trial of its vaccine, which could prevent many more group B Strep infections than current prevention strategies - not only the early-onset group B Strep infections (in babies aged 0-6 days), but also late-onset group B Strep infection (in babies 7-90 days) and potentially stillbirths and maternal infections caused by group B Strep. While a safe and effective vaccine is likely many years away, this is an important step towards eradicating group B Strep infection in babies. “We are delighted that Pfizer is developing a group B Strep vaccine. Group [...]
Eleven years ago Eli was born with a group B Strep infection. He couldn't breathe, and had to be resuscitated. It was touch and go in the Intensive Care Unit for days. All this because I wasn't tested. From that incredible magical moment you were placed in my arms, I knew how special you were. Overcoming GBS, we are lucky to have you and call you a survivor! You have shown such determination and continued to fight. We couldn't be prouder, you are just amazing and perfect in every single way. Click here to share your story click here to go Back to the GBS Book of Experience
On Wednesday 22nd March 2017, the UK National Screening Committee recommended that the Government should not introduce routine screening of pregnant women for group B Strep. We are hugely disappointed by this recommendation. Group B Streptococcus (GBS or Strep B) is the UK’s most common cause of life-threatening infection in newborn babies – causing sepsis, meningitis and pneumonia. Group B Strep is carried by around 20-30% of the population and, on average, in the UK: 2 babies a day develop group B Strep infection 1 baby a week dies from group B Strep infection 1 baby a week survives with disability The UK National Screening Committee have published a one-page recommendation statement, an evidence review summary and their last external review. We [...]